Do Decision-Analytic Models Identify Cost-Effective Treatments? A Retrospective Look at Helicobacter Pylori Eradication

BACKGROUND: Pharmacoeconomic models of Helicobacter (H) pylori eradication have been frequently cited but never validated. OBJECTIVES: Examine retrospectively whether H pylori pharmacoeconomic models direct decision makers to cost-effective therapeutic choices. METHODS: We first replicated and then...

Descripción completa

Detalles Bibliográficos
Autores principales: Fairman, Kathleen A., Motheral, Brenda R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437262/
https://www.ncbi.nlm.nih.gov/pubmed/14613441
http://dx.doi.org/10.18553/jmcp.2003.9.5.430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437262/
https://www.ncbi.nlm.nih.gov/pubmed/14613441
http://dx.doi.org/10.18553/jmcp.2003.9.5.430

Ejemplares similares